Stock CGTX COGNITION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
1.98 USD +1.54% Intraday chart for Cognition Therapeutics, Inc. +3.12% +7.03%
05-07 Cognition Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-29 Cognition Therapeutics, Inc. Completes Enrollment in Phase 2 SHIMmer Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cognition Therapeutics, Inc. Appoints Quang Pham as Board Director
CI
Cognition Therapeutics, Inc. Appoints John Doyle as Chief Financial Officer
CI
Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO
AN
Cognition Therapeutics, Inc. Announces Resignation of Mark H. Breedlove as Member of Board, Effective December 31, 2021
CI
Cognition Therapeutics, Inc. Announces Appointment of Ellen B. Richstone as Member of Board and Nominating and Corporate Governance Committee and Chair of Audit Committee
CI
Insider Buy: Cognition Therapeutics
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGTX Stock
  4. News Cognition Therapeutics, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW